Schizophrenia News and Research RSS Feed - Schizophrenia News and Research

Schizophrenia is a chronic debilitating disorder which affects more than two million Americans, and millions more worldwide. While significant progress has been made in understanding the disease and developing treatments, there remains a significant unmet medical need. More than 50% of patients switch their medication in a given year due to either poor response or the experience of adverse events.
New study to examine effectiveness of orally administered drug in treating stuttering

New study to examine effectiveness of orally administered drug in treating stuttering

Stuttering, an interruption in the flow of speech, affects about three million Americans. It begins most often in childhood, affecting four men for every woman. A precise cause of this complex communicative disorder is not known. [More]
Tendency to feel lonely linked partially to genetic traits

Tendency to feel lonely linked partially to genetic traits

Loneliness is linked to poor physical and mental health, and is an even more accurate predictor of early death than obesity. [More]
CBN neuroscientists awarded NIMH grant to develop novel genome engineering research tools

CBN neuroscientists awarded NIMH grant to develop novel genome engineering research tools

The Center for Behavioral Neuroscience at Georgia State University has received a two-year, exploratory grant from the National Institute of Mental Health to develop transformative genome engineering research tools. [More]
Review provides insights into principles of neurofeedback technique

Review provides insights into principles of neurofeedback technique

Neurofeedback is a technique used for the treatment of clinical disorders (like depression, anxiety, chronic pain, ADHD and schizophrenia etc.) and enhancement of brain performance. [More]
Second-generation survivors whose parents were babies during Holocaust at high risk of severe schizophrenia

Second-generation survivors whose parents were babies during Holocaust at high risk of severe schizophrenia

Results of a new study at the University of Haifa have found that no difference in the risk of developing schizophrenia between second-generations Holocaust survivors and those whose parents were not exposed to the Holocaust. [More]
Mood stabilizers may decrease negative symptoms in psychiatric patients with specific genotype

Mood stabilizers may decrease negative symptoms in psychiatric patients with specific genotype

A drug prescribed to many patients with schizophrenia or bipolar disorder may decrease negative symptoms for people with a certain variant of the COMT gene, suggests a new study from researchers at Columbia University Medical Center. [More]
Psychotropic drugs cannot alleviate symptoms of mental disorders, say researchers

Psychotropic drugs cannot alleviate symptoms of mental disorders, say researchers

Drugs don't lead to sustainable alleviation of mental disorders, as the psychologists Prof Dr J├╝rgen Margraf and Prof Dr Silvia Schneider claim in a commentary published in "EMBO Molecular Medicine". [More]
New mouse model helps identify potential drug target for hard-to-treat social aspects of ASD

New mouse model helps identify potential drug target for hard-to-treat social aspects of ASD

A study of a new mouse model identifies a drug target that has the potential to increase social interaction in individuals with some forms of autism spectrum disorder (ASD), according to researchers in the Perelman School of Medicine at the University of Pennsylvania. The team published their work in Biological Psychiatry. [More]
Schizophrenia drug slows pancreatic tumor growth in mice

Schizophrenia drug slows pancreatic tumor growth in mice

A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer -- and schizophrenia drugs, which block the function of this receptor, slowed tumor growth and metastatic spread in mice, according to researchers at McGill University and the German Cancer Research Center. [More]
Researchers use unique computational approach to identify promising drug leads for heart diseases

Researchers use unique computational approach to identify promising drug leads for heart diseases

Using a unique computational approach to rapidly sample, in millisecond time intervals, proteins in their natural state of gyrating, bobbing, and weaving, a research team from UC San Diego and Monash University in Australia has identified promising drug leads that may selectively combat heart disease, from arrhythmias to cardiac failure. [More]
Scientists discover brain circuit crucial to sleep-wake cycle

Scientists discover brain circuit crucial to sleep-wake cycle

Stanford University School of Medicine scientists have identified a brain circuit that's indispensable to the sleep-wake cycle. [More]
Neuroimaging: an insight into psychiatric causes? An interview with Dr Craig Buckley

Neuroimaging: an insight into psychiatric causes? An interview with Dr Craig Buckley

CUBRIC is one of the top neuroimaging research centres in the UK and has grown rapidly since it opened in 2006. CUBRIC is expected to become an international hub for neuroimaging, unique in Europe. [More]
Study reveals increasing prevalence of marijuana use among US adults

Study reveals increasing prevalence of marijuana use among US adults

An increasing number of US adults are using marijuana, as fewer people perceive the drug as harmful, according to a survey of over 500000 US adults conducted between 2002 and 2014 published in The Lancet Psychiatry. [More]
New collaborative initiative to develop novel ways of screening drugs for bipolar disorder, schizophrenia

New collaborative initiative to develop novel ways of screening drugs for bipolar disorder, schizophrenia

The Johns Hopkins University School of Medicine and the Salk Institute for Biological Studies will co-lead a $15.4 million effort to develop new systems for quickly screening libraries of drugs for potential effectiveness against schizophrenia and bipolar disorder, the National Institute of Mental Health (NIMH) has announced. [More]
Research reveals new insights into happy hormone, dopamine

Research reveals new insights into happy hormone, dopamine

Dopamine is a so-called messenger substance or neurotransmitter that conveys signals between neurons. [More]
Parental psychiatric diseases may lead to risk for suicide attempts and violent offending by children

Parental psychiatric diseases may lead to risk for suicide attempts and violent offending by children

Risk for suicide attempts and violent offending by children appears to be associated with their parents' psychiatric disorders, according to an article published online by JAMA Psychiatry. [More]
Antipsychotic use linked to higher pneumonia risk in patients with Alzheimer's disease

Antipsychotic use linked to higher pneumonia risk in patients with Alzheimer's disease

Antipsychotic medications are associated with an increased risk of pneumonia in persons with Alzheimer's disease (AD), according to new research from the University of Eastern Finland. [More]
New study suggests most American adults with depression receive no treatment

New study suggests most American adults with depression receive no treatment

New findings suggest that most Americans with depression receive no treatment, while raising the possibility that overtreatment of depression is also widespread. [More]
NIPS researchers reveal new mechanisms by which microglia sculpt neural circuits

NIPS researchers reveal new mechanisms by which microglia sculpt neural circuits

Microglia are cells that combat various brain diseases and injuries by swallowing foreign or disruptive objects and releasing molecules that activate repair mechanisms. [More]
Study explores relationship between moderate-vigorous exercise and psychotic symptoms

Study explores relationship between moderate-vigorous exercise and psychotic symptoms

Physical activity can help reduce cardiovascular disease and premature mortality in people with psychological problems. [More]
Advertisement